Publication|Articles|September 4, 2025
Supplements and Featured Publications
- CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
Listen
0:00 / 0:00
Advertisement
This supplement was sponsored by Johnson & Johnson and Legend Biotech.
In this AJMC® Roundtable discussion, healthcare decision makers examined barriers to timely access to CAR-T cell therapy and identified solutions to streamline approval processes and enhance payer education for improved patient care.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA
5